Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-08

Clinical Trial Update: Norspan Transdermal Patches Study in Osteoarthritis Patients [Phase 1]

View source ↗

Summary

A Phase 1 study of Norspan Transdermal Patches for osteoarthritis has completed recruitment/status, with the trial now finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norspan Transdermal Patches (buprenorphine)

Snippet

Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Osteoarthritis Disorders | Phase 1 | Status: COMPLETED